Be Biopharma Unveils BeCoMe-9 Trial and Presents on Versatile B Cell Medicines Platform December 9, 2024
TScan Therapeutics Named a Top Place to Work by The Boston Globe for Three Consecutive Years December 6, 2024
AAVantgarde Bio Announces FDA Orphan Drug Designation for AAVB-081 for the Treatment of Usher Syndrome Type 1B Retinitis Pigmentosa December 2, 2024
Rectify Pharma Presents Preclinical Data Supporting Development of Lead Candidate RTY-694 November 19, 2024
TScan Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update November 13, 2024
